Category: Steris Corp.
Steris and Synergy Health say they'll fight the U.S. Federal Trade Commission's move to block their proposed $1.8 billion merger.
Steris and Synergy Health postpone a shareholder vote on their proposed merger in order to comply with an information request from the U.S. Federal Trade Commission.
Steris (NYSE:STE) and Synergy Health postponed a shareholder vote on their proposed merger in order to comply with an information request from the U.S. Federal Trade Commission.
A federal appeals court upholds the dismissal of a patent infringement lawsuit brought by Cygnus Medical against Steris and Medtrica.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: U.K. regulators OK $2B Steris merger with Synergy Health; Hospira beats earnings forecasts for Q4, 2014; U.K. regulators pass on probe of Zoll Medical's Philips InnerCool buy; William Demant in talks to buy French hearing aid retailer Audika
Zoll Medical Corp.
, Costco Wholesale Corp.
, Hospira Inc.
, Pfizer Inc.
, Royal Philips
, Sonova Holding AG
, Steris Corp.
, Synergy Health
, U.K. Competition and Markets Authority
, William Demant Holding
U.K. regulators approve the proposed $2 billion inversion merger between Steris and Synergy Health.
The U.S. Federal Trade Commission wants more information from Steris Corp. and Synergy Health on their proposed, $2 billion inversion merger.
An EPA advisory panel meeting that began today could disrupt medical device supply chains if the panel upholds the agency's classification of a ubiquitous sterilizer as carcinogenic.
A scientific advisory panel to the EPA is convening today to evalute the environmental watchdog's determination that a common medical device sterilizer, ethylene oxide, is carcinogenic.
If the panel confirms that assessment, medtech companies warn, it could disrupt the supply chain for their lifesaving products.